SMA Solar (S92) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 Mar, 2026Executive summary
Group sales for 2025 were €1,516 million, nearly flat year-over-year, with Large Scale division growth offsetting a sharp decline in Home & Business Solutions (HBS).
Reported group EBITDA was €-65 million, impacted by significant one-off items including inventory devaluations, scrappage, and restructuring provisions.
Free cash flow turned positive at €110 million, a significant improvement from €-184 million in 2024, driven by net working capital optimization.
Order backlog remained strong at €1,352 million, providing visibility for 2026.
Net income fell to -€181.1 million, with EPS at -€5.22, reflecting impairments and restructuring costs.
Financial highlights
Large Scale division sales rose to €1,268.8 million in 2025, while HBS sales dropped to €247.2 million, down 30%.
Operating group EBITDA before one-offs was €107 million, down from €148 million in 2024.
Reported EBIT margin for the group was -12% (2024: 6%); operating EBIT margin was 3.6% (2024: 6.3%).
Net working capital decreased to €230 million (2024: €473 million), with a ratio of 14%.
Net cash more than doubled to €176 million; total cash at year-end was €222 million.
Outlook and guidance
2026 sales guidance: €1,475–1,675 million; EBITDA: €50–180 million.
Large Scale division expected to see slightly higher sales, but EBIT to be lower due to higher service costs and less capitalized R&D.
HBS sales and EBIT expected above 2025, but HBS still not profitable.
Cost reductions and efficiency gains from restructuring to positively impact 2026 EBITDA.
Persistent uncertainty from trade barriers, geopolitical conflicts, and new EEG legislation.
Latest events from SMA Solar
- Large Scale growth offsets Home and C&I declines; cash flow and outlook remain pressured.S92
Q2 20242 Feb 2026 - Sharp sales and earnings drop, major restructuring, but Large Scale segment outperforms.S92
Q3 202414 Jan 2026 - 2024 sales and EBITDA declined, but restructuring aims for recovery and EBIT improvement in 2025.S92
Q4 202424 Dec 2025 - Large Scale growth offset weak Home and C&I, with cautious outlook amid tariff and market risks.S92
Q1 202525 Nov 2025 - Sales and margins fell in H1 2025, but cash flow and restructuring efforts improved outlook.S92
Q2 202523 Nov 2025 - Large Scale growth offset by HBS losses and major restructuring; outlook remains challenging.S92
Q3 202517 Nov 2025 - Revenue and earnings fell sharply in 2024, driving a renewed focus on efficiency and innovation.S92
AGM 2025 Presentation1 Jul 2025